Home Antibody All anti-PSENEN antibodies
Also for PSENEN (NM_172341)
|PEN2 antibody was raised against a 13 amino acid peptide from near the carboxy terminus of human PEN2.|
|Human, Mouse, Rat
||ELISA, WB: 0.5 - 2 ug/ml, IF
|PBS containing 0.02% sodium azide.|
|Affinity chromatography purified via peptide column
|Homo sapiens presenilin enhancer gamma secretase subunit (PSENEN), transcript variant 1|
|MDS033; MSTP064; PEN-2; PEN2|
|PEN2, in addition to presenilin, nicastrin, and APH-1 forms the gamma-secretase protein complex, a membrane-bound aspartyl protease that can cleave certain proteins at peptide bonds buried within the hydrophobic environment of the lipid bilayer. This cleavage is responsible for a key step in signaling from several cell-surface receptors and is thought to be required for the generation of the neurotoxic amyloid peptides that are central to the pathogenesis of Alzheimer’s disease. Like the tumor necrosis factor-alpha-converting enzyme (TACE) and the beta-site cleavage enzyme (BACE) protease families, gamma-secretase will cleave the amyloid precursor protein (APP), but within the intramembrane region of APP, resulting in either the non-toxic p3 (from the alpha and gamma cleavage site) or the toxic A?beta amyloid peptide (from the beta and gamma cleavage site). It is thought that accumulation of the Abeta peptide is the precursor to Alzheimer’s disease.|
Delta-Notch Signaling Pathway
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of PEN2 in K562 cell lysate with PEN2 antibody at (A) 0.5, (B) 1, and (C) 2 ug/mL.
Immunofluorescence of PEN2 in K562 cells with PEN2 antibody at 20 ug/mL.